克罗恩病与溃疡性结肠炎患者的围手术期和术后管理
本文综述炎症性肠病(IBD)患者围手术期与术后管理的多学科策略:讨论术前免疫抑制治疗的安全性最新证据;讨论克罗恩病(CD)肠切除术后医学管理,重点为风险分层与术后早期治疗选择;并回顾回肠储袋肛管吻合术(IPAA)术后并发症及处理。
要点
- IBD手术仍是治疗的重要组成部分,围手术期与术后需多学科管理以改善结局。
- 术前需评估生物制剂等免疫抑制治疗的安全性,权衡手术时机与用药。
- CD肠切除术后应进行风险分层,并据此选择术后早期治疗方案。
核心结论
- IBD患者围手术期与术后管理应采用多学科策略,以改善手术相关结局。
- 克罗恩病肠切除术后需重视风险分层与术后早期治疗选择。
- 回肠储袋肛管吻合术(IPAA)术后并发症需识别并管理。
研究设计与样本
- 综述,总结IBD围手术期与术后管理的多学科策略;原文未报告检索范围与样本量。
主要发现
- 生物制剂新机制不断出现,当前治疗时代倡导更早、可能更积极的免疫抑制治疗策略。
- 综述讨论了术前免疫抑制治疗安全性的最新证据。
- 综述聚焦克罗恩病肠切除术后风险分层与术后早期治疗选择。
- 综述回顾了IPAA术后潜在并发症及其管理。
临床怎么用
- 对需手术的IBD患者,术前应多学科评估免疫抑制治疗安全性并制定围手术期用药策略。
- 克罗恩病肠切除术后按风险分层选择术后早期治疗。
- IPAA术后应关注并处理相关并发症。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Although the number of available therapies for the treatment of ulcerative colitis and Crohn's disease (CD) continues to expand, a significant portion of patients with inflammatory bowel disease will require surgical intervention. Surgery remains an integral part of the treatment algorithm for patients with ulcerative colitis and CD, and thus multidisciplinary approaches to the perioperative and postoperative management of patients with inflammatory bowel disease are critical to improving outcomes during these periods. New mechanisms of biologic therapies are emerging and new treatment strategies focused on earlier and potentially more aggressive use of immunosuppressive therapies are advocated in the current treatment era. In this review, we outline multidisciplinary strategies for the preoperative management of immunosuppressive therapies, including a discussion of the most recent evidence regarding the safety of biologic therapy in the preoperative period. We also discuss the postoperative medical management of patients undergoing intestinal resection for CD, with a particular focus on risk stratification and appropriate therapy selection in the immediate postoperative setting. Finally, we review potential postoperative complications after restorative proctocolectomy with ileal pouch-anal anastomosis and their management.
引用
- Barnes EL, Lightner AL, Regueiro M, et al. Perioperative and Postoperative Management of Patients With Crohn's Disease and Ulcerative Colitis. Clin Gastroenterol Hepatol. 2019. PMID: 31589972. doi:10.1016/j.cgh.2019.09.040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。